Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

86
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
86
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

65
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
65
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

81
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
81
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Nephrons01:10

Nephrons

3.4K
The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
3.4K
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

71
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
71

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term eculizumab treatment failure in C3 glomerulonephritis: two case reports.

Clinical kidney journal·2026
Same author

Extracellular vesicles exposing complement split products are associated with kidney involvement in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).

RMD open·2026
Same author

Effects of Semaglutide on Body Composition and GFR: A Prespecified Analysis of the SMART Trial.

Clinical journal of the American Society of Nephrology : CJASN·2026
Same author

Uromodulin and Tryptophan Metabolite Clearance in Hemodialyzed Patients.

Journal of clinical medicine·2026
Same author

The evolving field of nephrology: what comes next? A report from the European Renal Association Scientific Advisory Board.

Clinical kidney journal·2026
Same author

Avacopan in a compassionate use programme for severe anti-neutrophil cytoplasmic antibody-associated vasculitis in Sweden.

Scandinavian journal of rheumatology·2026

Related Experiment Video

Updated: Sep 9, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

833

Long COVID and the kidney.

Vanja Ivković1, Urmila Anandh2, Samira Bell3

  • 1Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden. vanja.ivkovic@gmail.com.

Nature Reviews. Nephrology
|September 4, 2025
PubMed
Summary
This summary is machine-generated.

Long COVID, a persistent condition after SARS-CoV-2 infection, can lead to chronic kidney disease (CKD). Vaccination against SARS-CoV-2 is crucial for preventing severe COVID-19 and long COVID, especially in CKD patients.

More Related Videos

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
04:37

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis

Published on: April 25, 2025

770
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

278

Related Experiment Videos

Last Updated: Sep 9, 2025

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

833
Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis
04:37

Unilateral Ureteral Obstruction Model for Investigating Kidney Interstitial Fibrosis

Published on: April 25, 2025

770
Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

278

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Public Health

Background:

  • Long coronavirus disease (COVID) is a complex condition affecting multiple organ systems, including the kidneys, persisting for over three months post-SARS-CoV-2 infection.
  • COVID-19 is linked to acute kidney injury and an increased risk of chronic kidney disease (CKD), suggesting CKD as a potential manifestation of long COVID.
  • Patients with pre-existing CKD face higher risks of severe COVID-19 and developing long COVID.

Purpose of the Study:

  • To explore the multifaceted impact of COVID-19 on kidney health, including the development and progression of chronic kidney disease.
  • To highlight the bidirectional relationship between COVID-19, long COVID, and chronic kidney disease.
  • To emphasize the role of SARS-CoV-2 vaccination in mitigating risks associated with COVID-19 and long COVID, particularly for vulnerable CKD populations.

Main Methods:

  • Review of existing literature and studies investigating the renal manifestations of COVID-19 and long COVID.
  • Analysis of reported associations between SARS-CoV-2 infection and kidney diseases, including COVID-19-associated nephropathy and vasculitis.
  • Evaluation of the impact of SARS-CoV-2 vaccination on COVID-19 and long COVID incidence in the general population and CKD patients.

Main Results:

  • COVID-19 can cause acute kidney injury and is associated with an increased risk of developing chronic kidney disease (CKD).
  • Specific kidney conditions like collapsing glomerulopathy and new-onset vasculitis have been linked to COVID-19.
  • SARS-CoV-2 vaccination significantly reduces the risk of COVID-19 and long COVID, offering protection to all individuals, especially those with CKD.

Conclusions:

  • Chronic kidney disease (CKD) can be a significant sequela of long COVID, necessitating ongoing research and monitoring.
  • The interplay between COVID-19 and CKD underscores the importance of comprehensive care for affected patients.
  • Structured follow-up for COVID-19 survivors is essential to understand long COVID trajectories and identify individuals at risk for CKD.